Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant human esoderma colyone adenovirus, and its preparing method and use

An endostatin and adenovirus technology, applied in the field of genetic engineering, can solve the problems of complex and time-consuming protein purification process, large clinical application limitations and high cost, and achieve growth and migration inhibition, growth and migration inhibition, and increase administration time. The effect of the interval

Active Publication Date: 2007-03-28
GUIZHOU BAILING GRP PARMACEUTIAL CO LTD
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, it is believed that angiogenesis inhibitors, a large class of proteins, have many limitations in treatment: First, due to their pharmacokinetic characteristics, the protein molecules expressed in vitro are unstable, which determines that protein infusion is a long-term, repeated, and sufficient treatment. The large dosage and short-term multiple infusions have brought great inconvenience to patients; in addition, the protein purification process is complicated, time-consuming, low yield, high cost, and relatively limited clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant human esoderma colyone adenovirus, and its preparing method and use
  • Recombinant human esoderma colyone adenovirus, and its preparing method and use
  • Recombinant human esoderma colyone adenovirus, and its preparing method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Example 1 Preparation of human endostatin gene

[0051] In this example, the RT-PCR method was used to amplify human endostatin cDNA fragments from the total RNA of human liver.

[0052] Design and synthesize RT-PCR primers based on the human endostatin gene sequence. In order to insert the PCR product directly into the cloning vector-pUC18 (purchased from Invitrogen), the 5'and 3'primers are designed with BaMH I restriction sites Point, the primer sequence is as follows:

[0053] 5’ Primer: 5’CGG GAT CCA CAG CCA CCG CGA CTT CCA GCC 3’

[0054] 3’ Primer: 5’GCG GAT CCT ACT TGG AGG CAG TCA TGA AGC 3’

[0055] The RT-PCR conditions are as follows:

[0056] After the RT-PCR reaction mixture was denatured at 50°C for 30 minutes, the reaction was carried out under the following conditions:

[0057] Reverse transcription reaction: denaturation at 94°C for 30 seconds; annealing at 50°C for 30 seconds; extension at 68°C for 1 minute. Reaction for 10 cycles.

[0058] PCR reaction: d...

Embodiment 2

[0060] Example 2 Preparation of human endostatin gene encoding human IL-2 gene signal peptide

[0061] With reference to the cDNA sequence of human IL-2 (GI: 28178860), the PCR primers were designed and synthesized as follows:

[0062] 5’ Primer: 5’CGG ATC CAT GTA CAG GAT GCA ACT CCT GTC TTG CAT TGCACT AAG TCT TGC ACT TGT CAC GAA TTC GGC CCA CAG CCA CCG CGA CTTCCA GCC 3’

[0063] 3’ Primer: 5’GCG GAT CCT ACT TGG AGG CAG TCA TGA AGC 3’

[0064] Both the 5'primer and the 3'primer are designed with BamH I restriction sites, which are directly inserted into the shuttle vector pAdenovator-CMV5; the italic part of the 5'primer is the signal peptide sequence of human IL-2.

[0065] Then use pUC18-endo as a template to amplify the human endostatin DNA fragment containing the IL-2 gene signal peptide. The PCR conditions are as follows:

[0066] Denaturation at 94°C for 30 seconds; annealing at 55°C for 30 seconds; extension at 72°C for 30 seconds. Reaction for 30 cycles. Then extend for an...

Embodiment 3

[0068] Example 3 Construction and screening of recombinant adenovirus

[0069] 1. The cloned human endostatin gene containing human IL-2 signal peptide was constructed into pAdenoVator-CMV5 shuttle vector, and then combined with the circular plasmid pAdenoVatorΔE1E3 (purchased from Qbiogene) containing adenovirus genome (E1, E3 deletion) ) Co-transform Escherichia coli BJ5183 (purchased from Qbiogene) with conventional electroporation methods, and screen recombinant pAd-endo for identification. The results showed that the recombinant pAd-endo(1) and pAd-endo(3) with two recombination sites were screened separately (see Figure 3). The homologous recombination site is located in the left arm to cut out a fragment of 3.0 kb, and the recombination site is located in the replicon to cut out a fragment of 4.5 kb in size.

[0070] 2. The linearized recombinant plasmid pAd-endo and lipofectamine (purchased from Invitrogen) were co-transfected into 293 cells (purchased from ATCC) using con...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention supplies a new recombination endostatin gene that connects the 3' end of IL-2 gene signal peptide sequence with the 5' end of endostatin coding sequence, and the gene could be constructed into adenovirus and make anti-tumor injection. The injection would restrain the growth and transferring of tumor in body and keep entire bioactivity. It has the advantages of lowering medicine cost, improving life quality of patients and good market prospect.

Description

Technical field [0001] The present invention relates to the field of genetic engineering, in particular to an adenovirus containing recombinant human endostatin gene and its preparation method and application. Background technique [0002] In 1971, Folkman first put forward the view that tumor growth and metastasis are vascular-dependent. Studies in recent decades have continuously confirmed this view. The occurrence, development and metastasis of tumors are closely related to tumor angiogenesis, which is an important control point for tumor growth and metastasis (Skobe et al., 1997; Dameron et al. ., 1994; Volpert et al., 1997; Bertolini et al., 2000; Holmgren et al., 1995). Tumor anti-angiogenesis therapy has become a new research direction in tumor therapy. [0003] Endostatin (endostatin) is the most famous endogenous angiogenesis inhibitor discovered by O'Reilly et al in 1997. It is the C-terminal fragment of collagen XVIII (derived from human endostatin protein contains 183...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/12C12N15/62C07K14/435C12N15/63C12N15/86C12N15/79A61K48/00A61P35/00C12N15/10A61K38/17
Inventor 魏于全杨莉
Owner GUIZHOU BAILING GRP PARMACEUTIAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com